FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309610079> ?p ?o ?g. }

• W4309610079 abstract "The rising cost of oncological drugs poses a global challenge to patients, insurers, and policy makers, with the leading drugs worldwide by revenue from immune checkpoint inhibitors (ICIs). Despite its cost, ICI is marked as a paradigm shift, offering the potential of a long-term cure. To reduce cost, an attenuated dose of ICI based on pharmacological principles can be used while maintaining efficacy. This real-world study aims to examine the prescribing patterns, the effect of financial constraints, and the outcomes in non-small cell lung cancer (NSCLC). All patients receiving palliative intent ICI treatment for advanced NSCLC between January 2014 and April 2021 in National University Hospital, Singapore were recruited. Demographics, prescription trends, factors affecting the prescription of attenuated dose ICI (AD ICI) versus standard dose ICI (SD ICI), and the effect of dose on survival outcomes, toxicities, and costs were examined. Two hundred seventy-four received ICI. The majority of them were treated in first-line setting. One hundred sixty-two (59%) of patients received AD ICI, whereas 112 (41%) received SD ICI. Patients who did not have a supplemental private as-charged health insurance plan were more likely to have received AD ICI (OR: 4.53 [2.69–7.61] p &lt; 0.001). There was no difference in progression-free survival (PFS) and overall survival (OS)—adjusted HR 1.07 CI [0.76, 1.50] p = 0.697 and HR 0.95 CI [0.67, 1.34] p = 0.773, respectively, between patients who received AD versus SD ICI. A cost minimization analysis evaluating the degree of cost savings related to drug costs estimated a within study cost saving of USD 7,939,059 over 7 years. Our study provides evidence for AD-ICI as a promising strategy to maximize the number of patients who can be treated with ICI. This has the potential to make significant economic impact and allow more patients to benefit from novel therapies." @default.
• W4309610079 created "2022-11-28" @default.
• W4309610079 creator A5005798113 @default.
• W4309610079 creator A5033700679 @default.
• W4309610079 creator A5034814958 @default.
• W4309610079 creator A5041384528 @default.
• W4309610079 creator A5043184297 @default.
• W4309610079 creator A5076811155 @default.
• W4309610079 creator A5086362466 @default.
• W4309610079 date "2022-11-17" @default.
• W4309610079 modified "2023-10-01" @default.
• W4309610079 title "Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank)" @default.
• W4309610079 cites W2144206754 @default.
• W4309610079 cites W2266198524 @default.
• W4309610079 cites W2292373964 @default.
• W4309610079 cites W2328498588 @default.
• W4309610079 cites W2477757565 @default.
• W4309610079 cites W2536330680 @default.
• W4309610079 cites W2549531711 @default.
• W4309610079 cites W2588278598 @default.
• W4309610079 cites W2595781426 @default.
• W4309610079 cites W2605907793 @default.
• W4309610079 cites W2612703804 @default.
• W4309610079 cites W2620733650 @default.
• W4309610079 cites W2621194109 @default.
• W4309610079 cites W2745683917 @default.
• W4309610079 cites W2754001395 @default.
• W4309610079 cites W2800670743 @default.
• W4309610079 cites W2806388842 @default.
• W4309610079 cites W2882999865 @default.
• W4309610079 cites W2896954393 @default.
• W4309610079 cites W2910245285 @default.
• W4309610079 cites W2939283308 @default.
• W4309610079 cites W2949082582 @default.
• W4309610079 cites W2965322165 @default.
• W4309610079 cites W2970886433 @default.
• W4309610079 cites W2981845027 @default.
• W4309610079 cites W2986633517 @default.
• W4309610079 cites W3009099064 @default.
• W4309610079 cites W3016541505 @default.
• W4309610079 cites W3021452266 @default.
• W4309610079 cites W3030490955 @default.
• W4309610079 cites W3084470313 @default.
• W4309610079 cites W3100428711 @default.
• W4309610079 cites W3104828024 @default.
• W4309610079 cites W3129147406 @default.
• W4309610079 cites W3131433923 @default.
• W4309610079 cites W3164993995 @default.
• W4309610079 cites W3199335269 @default.
• W4309610079 cites W3200608261 @default.
• W4309610079 cites W3201987153 @default.
• W4309610079 cites W3213514574 @default.
• W4309610079 cites W4206567797 @default.
• W4309610079 cites W4210340546 @default.
• W4309610079 cites W4286698642 @default.
• W4309610079 doi "https://doi.org/10.3389/fonc.2022.932212" @default.
• W4309610079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36465401" @default.
• W4309610079 hasPublicationYear "2022" @default.
• W4309610079 type Work @default.
• W4309610079 citedByCount "0" @default.
• W4309610079 crossrefType "journal-article" @default.
• W4309610079 hasAuthorship W4309610079A5005798113 @default.
• W4309610079 hasAuthorship W4309610079A5033700679 @default.
• W4309610079 hasAuthorship W4309610079A5034814958 @default.
• W4309610079 hasAuthorship W4309610079A5041384528 @default.
• W4309610079 hasAuthorship W4309610079A5043184297 @default.
• W4309610079 hasAuthorship W4309610079A5076811155 @default.
• W4309610079 hasAuthorship W4309610079A5086362466 @default.
• W4309610079 hasBestOaLocation W43096100791 @default.
• W4309610079 hasConcept C121608353 @default.
• W4309610079 hasConcept C126322002 @default.
• W4309610079 hasConcept C143998085 @default.
• W4309610079 hasConcept C2426938 @default.
• W4309610079 hasConcept C2777288759 @default.
• W4309610079 hasConcept C71924100 @default.
• W4309610079 hasConcept C98274493 @default.
• W4309610079 hasConceptScore W4309610079C121608353 @default.
• W4309610079 hasConceptScore W4309610079C126322002 @default.
• W4309610079 hasConceptScore W4309610079C143998085 @default.
• W4309610079 hasConceptScore W4309610079C2426938 @default.
• W4309610079 hasConceptScore W4309610079C2777288759 @default.
• W4309610079 hasConceptScore W4309610079C71924100 @default.
• W4309610079 hasConceptScore W4309610079C98274493 @default.
• W4309610079 hasLocation W43096100791 @default.
• W4309610079 hasLocation W43096100792 @default.
• W4309610079 hasLocation W43096100793 @default.
• W4309610079 hasLocation W43096100794 @default.
• W4309610079 hasOpenAccess W4309610079 @default.
• W4309610079 hasPrimaryLocation W43096100791 @default.
• W4309610079 hasRelatedWork W1997686870 @default.
• W4309610079 hasRelatedWork W2008974290 @default.
• W4309610079 hasRelatedWork W2077474582 @default.
• W4309610079 hasRelatedWork W2144186891 @default.
• W4309610079 hasRelatedWork W2947337648 @default.
• W4309610079 hasRelatedWork W2947847159 @default.
• W4309610079 hasRelatedWork W3209628440 @default.
• W4309610079 hasRelatedWork W4225356780 @default.
• W4309610079 hasRelatedWork W4311128806 @default.
• W4309610079 hasRelatedWork W4382699942 @default.
• W4309610079 hasVolume "12" @default.

• next